Kinaxis Inc. (TSE:KXS) Stock Has Consensus Price Target of C$210.56 According to Analysts

Kinaxis Inc. (TSE:KXS – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight ratings firms that are presently covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is C$210.56.

KXS has been the topic of a number of research reports. Royal Bank Of Canada set a C$210.00 price target on shares of Kinaxis and gave the stock an “outperform” rating in a research note on Wednesday, August 26th. National Bank Financial increased their price objective on Kinaxis from C$210.00 to C$245.00 and gave the stock an “outperform” rating in a report on Monday, November 9th. Stifel Nicolaus lifted their price objective on Kinaxis from C$200.00 to C$225.00 and gave the company a “buy” rating in a research report on Thursday, October 29th. BMO Capital Markets boosted their target price on Kinaxis from C$195.00 to C$200.00 and gave the company an “outperform” rating in a research note on Friday, August 7th. Finally, RBC Dominion Securities set a C$210.00 target price on Kinaxis and gave the company an “outperform” rating in a research note on Friday, October 23rd.

Check Out Our Latest Stock Analysis on Kinaxis

Insiders Place Their Bets

In related news, insider Andrew William Robert Bell sold 3,000 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of C$179.48, for a total transaction of C$538,440.00. Following the completion of the sale, the insider owned 1,455 shares in the company, valued at C$261,143.40. This represents a 67.34% decrease in their position. Also, insider James Alexander Hollingworth sold 2,150 shares of the stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of C$178.94, for a total value of C$384,721.00. Following the completion of the sale, the insider directly owned 4,772 shares of the company’s stock, valued at C$853,901.68. This represents a 31.06% decrease in their ownership of the stock. Insiders sold 13,076 shares of company stock worth $2,335,260 in the last three months. 1.20% of the stock is owned by insiders.

Kinaxis Price Performance

Kinaxis stock traded up C$1.10 during midday trading on Friday, hitting C$229.24. The company’s stock had a trading volume of 197,561 shares, compared to its average volume of 129,074. Kinaxis has a 12 month low of C$117.22 and a 12 month high of C$231.91. The company has a quick ratio of 2.29, a current ratio of 1.81 and a debt-to-equity ratio of 11.18. The company has a market capitalization of C$6.21 billion, a PE ratio of 71.64, a price-to-earnings-growth ratio of 3.60 and a beta of 0.43. The stock’s 50-day moving average price is C$187.40 and its 200-day moving average price is C$158.41.

Kinaxis (TSE:KXS – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported C$1.72 earnings per share (EPS) for the quarter. Kinaxis had a return on equity of 22.26% and a net margin of 14.33%. The company had revenue of C$228.16 million for the quarter. Analysts anticipate that Kinaxis will post 4.25 earnings per share for the current fiscal year.

About Kinaxis

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

Further Reading

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.